Literature DB >> 19654508

Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats.

Tauheed Ishrat1, Kehkashan Parveen, Md Nasrul Hoda, Mohammad Badruzzaman Khan, Seema Yousuf, Mubeen Ahmad Ansari, Sofiyan Saleem, Fakhrul Islam.   

Abstract

Oxidative stress plays a crucial role in the progression of cognitive decline in Alzheimer's disease (AD). Considerable attention has been focused on increasing the internal antioxidant defenses in response to AD. This study was designed to examine and compare the pretreatment effects of Pycnogenol (PYC) and vitamin E (Vit E) on cognitive deficits and oxidative damage in the hippocampus and cerebral cortex of intracerebroventricular streptozotocin (ICV-STZ)-infused rats. Rats pretreated with PYC (10 mg/kg), Vit E (100 mg/kg), and vehicle (intraperitoneal; once daily for 3 weeks) were bilaterally injected with ICV-STZ (3 mg/kg), whereas sham rats received the same volume of vehicle. After 2 weeks of ICV-STZ infusion, rats were tested for cognitive performance using passive avoidance and water maze tasks, and then killed for biochemical assays. ICV-STZ induced significant declines in cognitive performance and choline acetyltransferase activity in the hippocampus, which were significantly attenuated with PYC and Vit E. Pretreatment with PYC and Vit E produced a significantly enhanced glutathione level and Na+/K+-ATPase activity and decreased thiobarbituric acid reactive substances and protein carbonyl. These findings suggest that PYC and Vit E may provide a promising approach for the treatment of oxidative stress-related neurodegeneration in conditions such as AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19654508     DOI: 10.1097/FBP.0b013e32832c7125

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  7 in total

1.  Cognitive assessment of pycnogenol therapy following traumatic brain injury.

Authors:  Stephen W Scheff; Kelly N Roberts
Journal:  Neurosci Lett       Date:  2016-10-11       Impact factor: 3.046

2.  Neuroprotective effects of Bacopa monnieri in experimental model of dementia.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Neurochem Res       Date:  2012-06-15       Impact factor: 3.996

Review 3.  What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research.

Authors:  Melita Salkovic-Petrisic; Ana Knezovic; Siegfried Hoyer; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-08-12       Impact factor: 3.575

4.  Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Ramasamy Thangavel; Asgar Zaheer
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

5.  Stuck at the bench: Potential natural neuroprotective compounds for concussion.

Authors:  Anthony L Petraglia; Ethan A Winkler; Julian E Bailes
Journal:  Surg Neurol Int       Date:  2011-10-12

Review 6.  Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.

Authors:  José J Jarero-Basulto; Martha C Rivera-Cervantes; Deisy Gasca-Martínez; Francisco García-Sierra; Yadira Gasca-Martínez; Carlos Beas-Zárate
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-26

7.  Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol.

Authors:  Mahsa Malekahmadi; Omid Moradi Moghaddam; Sheikh Mohammed Shariful Islam; Kiarash Tanha; Mohsen Nematy; Naseh Pahlavani; Safieh Firouzi; Mohammad Reza Zali; Abdolreza Norouzy
Journal:  Trials       Date:  2020-02-11       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.